IS7888A - Fínasteríðsamsetningar - Google Patents

Fínasteríðsamsetningar

Info

Publication number
IS7888A
IS7888A IS7888A IS7888A IS7888A IS 7888 A IS7888 A IS 7888A IS 7888 A IS7888 A IS 7888A IS 7888 A IS7888 A IS 7888A IS 7888 A IS7888 A IS 7888A
Authority
IS
Iceland
Prior art keywords
fínasteríðsamsetningar
Prior art date
Application number
IS7888A
Other languages
English (en)
Other versions
IS2943B (is
Inventor
Johannsson Fjalar
Irnason Birkir
Original Assignee
Actavis Group Hf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Hf. filed Critical Actavis Group Hf.
Publication of IS7888A publication Critical patent/IS7888A/is
Publication of IS2943B publication Critical patent/IS2943B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS7888A 2002-11-22 2005-06-10 Fínasteríðsamsetningar IS2943B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
PCT/IS2003/000034 WO2004047798A2 (en) 2002-11-22 2003-11-21 Formulations of finasteride

Publications (2)

Publication Number Publication Date
IS7888A true IS7888A (is) 2005-06-10
IS2943B IS2943B (is) 2016-03-15

Family

ID=36700777

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
IS7888A IS2943B (is) 2002-11-22 2005-06-10 Fínasteríðsamsetningar

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum

Country Status (5)

Country Link
US (1) US20060099251A1 (is)
EP (1) EP1575555B1 (is)
AU (1) AU2003302372A1 (is)
IS (2) IS6633A (is)
WO (1) WO2004047798A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
DK2200431T3 (en) 2007-09-10 2016-08-15 Boston Biomedical Inc UNKNOWN COMPOSITIONS AND PROCEDURES FOR CANCER TREATMENT
AU2011227023B2 (en) 2010-03-19 2015-05-28 Boston Biomedical, Inc. Novel methods for targeting cancer stem cells
KR20130060326A (ko) 2010-11-22 2013-06-07 한-민 첸 모발 성장 촉진제
PL2465581T3 (pl) 2010-12-15 2020-07-13 Energenesis Biomedical Co., Ltd. Nieterapeutyczne zastosowanie kompozycji do pobudzania wzrostu włosów
BR112015025347A2 (pt) 2013-04-09 2017-07-18 Boston Biomedical Inc 2-acetil-nafto [2-3-b] furan-4,9-diona para uso no tratamento do câncer
EP3002005A1 (en) * 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direct compression excipient based on lactose, cellulose and starch
AU2017305305A1 (en) * 2016-08-02 2019-02-21 Durect Corporation Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, carboxymethyl cellulose and polyoxylglyceride
US11299469B2 (en) 2016-11-29 2022-04-12 Sumitomo Dainippon Pharma Oncology, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
CN108853047A (zh) * 2018-07-25 2018-11-23 江苏黄河药业股份有限公司 一种非那雄胺片及其制备方法
CN109453134A (zh) * 2018-12-03 2019-03-12 海南赛立克药业有限公司 一种含非那雄胺的药物组合物及其制备方法
GB2610163B (en) * 2021-08-12 2023-12-13 Netriver Systems Ltd Secure online exchange of digital identification

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
GB9717428D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
GB9717444D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
JP2001520984A (ja) * 1997-10-27 2001-11-06 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 水難溶性薬剤の固態溶剤及び固体分散体
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents

Also Published As

Publication number Publication date
AU2003302372A1 (en) 2004-06-18
EP1575555B1 (en) 2014-08-06
IS2943B (is) 2016-03-15
IS6633A (is) 2004-05-23
WO2004047798A2 (en) 2004-06-10
EP1575555A2 (en) 2005-09-21
AU2003302372A8 (en) 2004-06-18
US20060099251A1 (en) 2006-05-11
WO2004047798A3 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
ATE457980T1 (de) Aryloxime
ATE534648T1 (de) C-6-modifizierte indazolylpyrrolotriazine
NO20043626L (no) Formoterolsuperfinformulering
DE50310083D1 (de) Phthalocyaninpigmentzubereitungen
ATE427876T1 (de) Luftkissenboot
ATE318817T1 (de) Aza-arylpiperazine
DE50212349D1 (de) Hirurgie
DE50212360D1 (de) Anfahrhilfesteuerungsvorrichtung
DE50301200D1 (de) Wischblatt
IS7888A (is) Fínasteríðsamsetningar
ATE349458T1 (de) Etonogestrelester
FI20020700A0 (fi) Sähkösuodatinrakenne
DE50309536D1 (de) Fadenabsaugvorrichtung
ATA1572002A (de) Managementspleisskassette
DE50307971D1 (de) Gelenklager
DE50309499D1 (de) Librierwerkzeugen
DE50302660D1 (de) Stopfmachine
ATE469773T1 (de) Zugöse
ATA4142004A (de) Trägerverbau
DE50303317D1 (de) Einschub-leistungsschalter
ATA19152002A (de) Hubkupplung
DE50310701D1 (de) Magnetfuehrungseinrichtung
DE50308979D1 (de) Einspritzventil
DE50300322D1 (de) Zylinderkopfdichtung
DE50303658D1 (de) Postgutmessvorrichtung